ARENA - Project Atrial Fibrilation Rhine-Neckar Region

Completed

• Conditions: Atrial Fibrillation

• Registration Number: NCT02978248
• Lead Sponsor: Stiftung Institut fuer Herzinfarktforschung

Brief Summary

ARENA aims to inform patients about the symptoms and the risks of atrial fibrilation.

The study design includes three study arms:

1. ARENA Intervention: This project will examine the effectiveness of population education.

2. ARENA Medication: The aim is to examine the patient's adherence and to analyze whether there are any complications.

3. ARENA Migration: ARENA migration aims to examine whether a targeted population education can improve the care of people with a Turkish migration background.

Detailed Description

ARENA aims to inform patients about the symptoms and the risks of atrial fibrilation.

The study design includes three study arms:

1. ARENA Intervention:

This project will examine the effectiveness of population education and other measures to provide care for patients with atrial fibrillation.

In the end of the control phase (1 year recruitment of approximately 10,000 patients), there will be a wide publicity, informing about the disease.

2. ARENA Medication:

ARENA records the patient's complete medication at all survey times (up to two weeks after recruitment and follow up). This allows an accurate assessment of interactions between individual substances.

In addition, attempts are being made to determine drug concentrations of anticoagulants directly by the blood of the patient. Therefore, patients are provided with kits, which they can use to apply a drop of blood from your fingertip to a filter paper. The aim is to examine the patient's adherence and to analyze whether there are any complications.

3. ARENA Migration:

The Metropolregion Rhein-Neckar is characterized by a high proportion of people with a Turkish migration background. ARENA migration aims to examine whether a targeted population education can improve the care of this patient group.

Study Timeline

• Study Start: 2016-08
• Study First Submitted: 2016-11-23
• Study First Submitted QC: 2016-11-28
• Study First Posted: 2016-11-30
• Primary Completion: 2018-12-31
• Study Completion: 2021-07-19
• Status Verified: 2022-05
• Last Update Submitted: 2023-04-11
• Last Update Posted: 2023-04-12

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 2777

Inclusion Criteria

• Willingness to participate
• Atiral fibrilation
• 18 years or older

Exclusion Criteria

• Not willing to participate

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Number of Prevented strokes in participants	10 years

Trial Locations

Locations (1)

Universitätsklinikum Heidelberg; 🇩🇪 Heidelberg, Baden-Württemberg, Germany